239 related articles for article (PubMed ID: 36581992)
1. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma.
Jiang A; Luo P; Chen M; Fang Y; Liu B; Wu Z; Qu L; Wang A; Wang L; Cai C
Cell Biosci; 2022 Dec; 12(1):209. PubMed ID: 36581992
[TBL] [Abstract][Full Text] [Related]
2. A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma.
Jiang A; Wu X; Wang D; Wang A; Dong K; Liu B; Qu L; Luo P; Wang J; Tong Q; Wang L
Front Immunol; 2022; 13():935595. PubMed ID: 35935986
[TBL] [Abstract][Full Text] [Related]
3. Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma.
Zhang F; Lin J; Feng D; Liang J; Lu Y; Liu Z; Wang X
Front Cell Dev Biol; 2022; 10():922995. PubMed ID: 36247012
[No Abstract] [Full Text] [Related]
4. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.
Jiang A; Liu Y; Zhu B; Fang Y; Qu L; Yang Q; Luo P; Cai C; Wang L
Clin Genitourin Cancer; 2024 Apr; 22(2):497-513. PubMed ID: 38245436
[TBL] [Abstract][Full Text] [Related]
5. The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma.
Qi X; Wang J; Che X; Li Q; Li X; Wang Q; Wu G
Am J Cancer Res; 2022; 12(8):3947-3966. PubMed ID: 36119838
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma.
Jiang A; Cai C; Yang Y; Cui Y; Liu W; Pang Q; Wu Z; Liu B; Qu L; Luo P; Wang A; Wang L
Oxid Med Cell Longev; 2023; 2023():3077091. PubMed ID: 36825082
[TBL] [Abstract][Full Text] [Related]
7. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309
[TBL] [Abstract][Full Text] [Related]
8. Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma.
Jiang A; Ye J; Zhou Y; Zhu B; Lu J; Ge S; Qu L; Xiao J; Wang L; Cai C
Cells; 2023 Jan; 12(3):. PubMed ID: 36766692
[TBL] [Abstract][Full Text] [Related]
9. A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Zhang WT; Gong YM; Zhang CY; Pan JS; Huang T; Li YX
Biomed Res Int; 2022; 2022():9196540. PubMed ID: 36105937
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related gene
Huang S; Cai C; Zhou K; Wang X; Wang X; Cen D; Weng G
Aging (Albany NY); 2023 Nov; 15(21):12314-12329. PubMed ID: 37938155
[TBL] [Abstract][Full Text] [Related]
11. Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study.
Jiang A; Pang Q; Gan X; Wang A; Wu Z; Liu B; Luo P; Qu L; Wang L
Cancer Innov; 2022 Aug; 1(2):146-167. PubMed ID: 38090653
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of the cuprotosis in tumor microenvironment and prognosis of gastric cancer.
Wang KW; Wang MD; Li ZX; Hu BS; Huang JF; Wu JJ; Yuan ZD; Wu XL; Yuan QF; Sun YF; Yuan FL
Heliyon; 2023 Mar; 9(3):e13831. PubMed ID: 36895378
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
[TBL] [Abstract][Full Text] [Related]
14. Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome
Jiang A; Meng J; Gong W; Zhang Z; Gan X; Wang J; Wu Z; Liu B; Qu L; Wang L
Front Immunol; 2022; 13():842069. PubMed ID: 35281041
[TBL] [Abstract][Full Text] [Related]
15. A Novel Cuprotosis-Related lncRNA Signature Effectively Predicts Prognosis in Glioma Patients.
Wu S; Ballah AK; Che W; Wang X
J Mol Neurosci; 2023 Mar; 73(2-3):185-204. PubMed ID: 36705778
[TBL] [Abstract][Full Text] [Related]
16. Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma.
Xiao J; Liu Z; Wang J; Zhang S; Zhang Y
Front Oncol; 2022; 12():941211. PubMed ID: 36110946
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
Front Oncol; 2021; 11():755212. PubMed ID: 34804944
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
19. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
Front Genet; 2021; 12():706661. PubMed ID: 34712264
[No Abstract] [Full Text] [Related]
20. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
